Odyssey: A Compelling Tale for Investors

S&P thinks this provider of hospice services is ready to post higher profits and fatter margins

We think that Odyssey Healthcare (ODSY: $13) will post earnings growth above its peers in the hospice-care industry. (Hospice services are designed to provide a wide range of care and services to terminally ill patients and their families.) In our view, management is taking the necessary steps to improve admissions trends and manage its exposure to the so-called Medicare cap—the fixed amount government insurance will pay per hospice-care beneficiary. We believe the company's new referral programs and additional service offerings will enhance revenue growth.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.